Akamatsu Yosuke, Gomez-Paz Santiago, Vergara-Garcia David, Moholkar Viraj M, Kuhn Anna Luisa, Chida Kohei, Singh Jasmeet, Rodrigues Katyucia de Macedo, Massari Francesco, Moore Justin M, Puri Ajit S, Ogilvy Christopher S, Thomas Ajith J
Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Department of Neurosurgery, Iwate Medical University, Yahaba, Japan.
Oper Neurosurg (Hagerstown). 2021 Mar 15;20(4):364-372. doi: 10.1093/ons/opaa423.
Intracranial dural arteriovenous fistulae (dAVFs) with cortical venous drainage (CVD) require treatment because of their aggressive clinical presentation and natural history. Although endovascular treatment is effective for the majority of these lesions in the current endovascular era, surgical management has been required if the lesions are not amenable to or fail endovascular treatments.
To demonstrate the angioarchitecture that may necessitate surgical intervention.
A retrospective review of the patients with intracranial dAVFs with CVD treated at 2 academic institutions between January 1, 2009, and July 31, 2019 was performed. Patients who required surgical intervention were selected in this study, and angiographic findings were analyzed.
A total of 81 dAVFs in 80 patients were treated during the study period. Endovascular treatments were attempted for 72 (88.9%) dAVFs, resulting in complete obliteration in 55 (76.4%). Surgical interventions were performed in 18 (22.2%) dAVFs, resulting in complete obliteration in all lesions. Overall, complete obliteration was achieved in 74 (93.7%) of 79 dAVFs with follow-up. In the surgically treated dAVFs, curative transarterial embolization was deterred by the angioarchitecture, which included dominant feeding vessels from the ophthalmic artery, meningohypophyseal trunk, posterior meningeal artery, pial artery, or ascending pharyngeal artery. Drainage through tortuous cortical vein, deep venous system, or isolated sinus made transvenous approach challenging.
Despite continued improvement in endovascular technology, surgical approaches to dAVFs are still of great value as initial and salvage treatment of dAVFs with angioarchitecture hampering endovascular treatment.
伴有皮质静脉引流(CVD)的颅内硬脑膜动静脉瘘(dAVF)因其侵袭性的临床表现和自然病程而需要治疗。在当前的血管内治疗时代,尽管血管内治疗对大多数此类病变有效,但如果病变不适合或血管内治疗失败,则需要进行手术治疗。
展示可能需要手术干预的血管构筑情况。
对2009年1月1日至2019年7月31日期间在2家学术机构接受治疗的伴有CVD的颅内dAVF患者进行回顾性研究。本研究选取了需要手术干预的患者,并对血管造影结果进行了分析。
在研究期间共治疗了80例患者的81个dAVF。对72个(88.9%)dAVF尝试了血管内治疗,其中55个(76.4%)实现了完全闭塞。对18个(22.2%)dAVF进行了手术干预,所有病变均实现了完全闭塞。总体而言,79个接受随访的dAVF中有74个(93.7%)实现了完全闭塞。在接受手术治疗的dAVF中,血管构筑情况阻碍了根治性经动脉栓塞,这些血管构筑包括来自眼动脉、脑膜垂体干、脑膜后动脉、软脑膜动脉或咽升动脉的主要供血血管。通过迂曲的皮质静脉、深部静脉系统或孤立静脉窦的引流使经静脉入路具有挑战性。
尽管血管内技术不断改进,但对于血管构筑阻碍血管内治疗的dAVF,手术方法作为初始治疗和挽救治疗仍具有重要价值。